
### [NCIT:C6875](http://purl.obolibrary.org/obo/NCIT_C6875)
**Label:** Large Cell Neuroendocrine Carcinoma

**Subclasses:** [NCIT:C96065](http://purl.obolibrary.org/obo/NCIT_C96065) (Small Intestinal Large Cell Neuroendocrine Carcinoma), [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96157](http://purl.obolibrary.org/obo/NCIT_C96157) (Colorectal Large Cell Neuroendocrine Carcinoma), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C95582](http://purl.obolibrary.org/obo/NCIT_C95582) (Pancreatic Large Cell Neuroendocrine Carcinoma), [NCIT:C40214](http://purl.obolibrary.org/obo/NCIT_C40214) (Cervical Large Cell Neuroendocrine Carcinoma), [NCIT:C6461](http://purl.obolibrary.org/obo/NCIT_C6461) (Thymic Large Cell Neuroendocrine Carcinoma), [NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma), [NCIT:C126323](http://purl.obolibrary.org/obo/NCIT_C126323) (Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma), [NCIT:C95985](http://purl.obolibrary.org/obo/NCIT_C95985) (Ampulla of Vater Large Cell Neuroendocrine Carcinoma), [NCIT:C95885](http://purl.obolibrary.org/obo/NCIT_C95885) (Gastric Large Cell Neuroendocrine Carcinoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C96426](http://purl.obolibrary.org/obo/NCIT_C96426) (Appendix Large Cell Neuroendocrine Carcinoma), [NCIT:C128245](http://purl.obolibrary.org/obo/NCIT_C128245) (Vulvar Large Cell Neuroendocrine Carcinoma), [NCIT:C126772](http://purl.obolibrary.org/obo/NCIT_C126772) (Endometrial Large Cell Neuroendocrine Carcinoma), [NCIT:C96958](http://purl.obolibrary.org/obo/NCIT_C96958) (Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma), [NCIT:C128075](http://purl.obolibrary.org/obo/NCIT_C128075) (Vaginal Large Cell Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [NCIT:C36821](http://purl.obolibrary.org/obo/NCIT_C36821) (Malignant Neuroendocrine Large Cell) 52.38%
- [NCIT:C36822](http://purl.obolibrary.org/obo/NCIT_C36822) (Malignant Epithelial Large Cell) and [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) 52.38%
- [NCIT:C36761](http://purl.obolibrary.org/obo/NCIT_C36761) (Neoplastic Neuroendocrine Cell) and [NCIT:C36822](http://purl.obolibrary.org/obo/NCIT_C36822) (Malignant Epithelial Large Cell) 52.38%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.74%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) and [NCIT:C37162](http://purl.obolibrary.org/obo/NCIT_C37162) (Neoplastic Large Cell) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38172](http://purl.obolibrary.org/obo/NCIT_C38172) (Cyclin D2 Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38169](http://purl.obolibrary.org/obo/NCIT_C38169) (A-myb Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38168](http://purl.obolibrary.org/obo/NCIT_C38168) (BCL-6 Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38167](http://purl.obolibrary.org/obo/NCIT_C38167) (CD10 Messenger RNA Overexpression))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma))) 37.74%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C38155](http://purl.obolibrary.org/obo/NCIT_C38155) (Recurrent Disease))) 37.74%


